Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Sistani pushed the 61-year-old company — famous for in-person meetings and portion control — to buy a telehealth platform that connected patients with doctors who can prescribe the popular obesity medications.X blocks links to hacked JD Vance dossier believed to be part of Iran attack, suspends journalist's accountTara Comonte, a board member who previously served as president of Shake Shack, has been tapped as interim CEO while the company mulls a full-time replacement.
The telehealth clinic allowed the company to begin dispensing GLP-1 drugs in addition to its traditional menu of behavioral change programs. But competition in the telehealth sector — particularly among companies that offer versions of the GLP-1 drugs — has hindered WeightWatchers.Last month, the company cut its full-year sales target and announced it would be streamlining its business in the face of a “rapidly changing landscape.”Prior to being named CEO in 2022, Sistani was co-founder and CEO of Houseparty, a video chat app that allowed up to 8 people to join a group call at any one time.
Celebrity Weight Loss Ozempic Weight Loss Weight Watchers
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk CEO Defends High Ozempic, Wegovy Prices at Congressional HearingNovo Nordisk CEO Lars Jorgensen faced intense scrutiny from lawmakers on Tuesday over the high prices of the company's weight-loss drugs Ozempic and Wegovy. Jorgensen argued that pharmacy benefit managers (PBMs) are responsible for a significant portion of drug costs, but lawmakers pressed him to take action to lower prices for American patients.
Read more »
Novo Nordisk CEO Grilled Over High Ozempic and Wegovy PricesLawmakers grilled Novo Nordisk CEO Lars Jorgensen over the high cost of weight-loss drugs Ozempic and Wegovy during a Tuesday hearing. Jorgensen placed some blame on pharmacy benefits managers, claiming they take 74 cents of every dollar the company makes.
Read more »
Novo Nordisk CEO Grilled Over High Prices of Weight-Loss Drugs Ozempic and WegovyDuring a Congressional hearing, Novo Nordisk CEO Lars Jorgensen faced pressure from lawmakers regarding the high prices of weight-loss drugs Ozempic and Wegovy. While Jorgensen attributed some costs to pharmacy benefit managers, he agreed to meet with them to discuss potential price reductions.
Read more »
Ozempic vs Wegovy: The Risks And Side Effects of Semaglutide DrugsThe Best in Science News and Amazing Breakthroughs
Read more »
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies FindNew trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
Read more »
How Ozempic, Wegovy, Mounjaro, Zepbound May Help Treat Other Diseases: Here’s What To KnowArianna Johnson is a reporter on the Forbes news desk who covers explainers and trends, with a frequent focus on health and science. She joined Forbes in 2022 and works in Texas. Johnson has covered prominent weight loss drugs like Ozempic and Wegovy, the health effects of the artificial sweetener aspartame and the impacts of the Covid vaccines.
Read more »